We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLNHP:NASDAQSoluna Holdings, Inc. - 9.0% Series A Cumulative Perpetual Preferred Stock Analysis

Data as of 2026-09-01 - not real-time

$12.53

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $12.53, Soluna Holdings, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 30.5% over the past 30 days. With RSI at 64.1 the momentum picture is approaching overbought, alongside a bearish MACD signal. Price has been bracketed by support at $10.98 and resistance at $12.77.
Revenue is growing at 144.6% on a -182.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 46.0%, a beta of 0.86 and a maximum drawdown of 45.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Yahoo Finance18dSoluna Holdings, Inc. - 9.0% Se SLNHP Q2 FY2026 earnings call transcriptSoluna delivered 145%...Seeking Alpha18dSoluna Holdings, Inc. SLNH Q2 2026 Earnings Call TranscriptGood afternoon, and thank you for joining...Benzinga.com1monSoluna Holdings Insider Trading Activity NASDAQ:SLNHP BenzingaInsider trading activity involves company...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 9.73
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 9.73
  • 30-day volatility of 46.0%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -182.2%
  • Negative return on equity of -68.4%
  • Revenue growth of +144.6%

Key Metrics & Analysis

Financial Health

Revenue Growth144.60%
Profit Margin-182.16%
ROE-68.36%
ROA-17.31%
Debt/Equity18.56
P/B Ratio18.0
Op. Cash Flow$-19431000
Free Cash Flow$-40091876
Industry P/E16.9

Technical Analysis

TrendBullish
RSI64.1
Support$10.98
Resistance$12.77
MA 20$12.04
MA 50$11.02
MA 200$9.73
MACDBearish
VolumeIncreasing
Fear & Greed Index93.11

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.86
Volatility46.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.